Table 8.
Top enriched KEGG pathways | Enrichment score | Gene count | P-Value | Benjamini valueb |
---|---|---|---|---|
Herpes simplex infection | 2.3 | 6 | 4.40E-06 | 2.90E-04 |
Viral myocarditis | 2.3 | 4 | 1.00E-04 | 3.40E-03 |
Graft-versus-host disease | 2.3 | 3 | 7.10E-04 | 1.60E-02 |
Allograft rejection | 2.3 | 3 | 8.60E-04 | 1.40E-02 |
Autoimmune thyroid disease | 2.3 | 3 | 9.40E-04 | 1.20E-02 |
Type I diabetes mellitus | 2.3 | 3 | 1.20E-03 | 1.30E-02 |
Antigen processing and presentation | 2.3 | 3 | 4.60E-03 | 4.30E-02 |
HTLV-1 infection | 2.3 | 4 | 7.90E-03 | 6.40E-02 |
Cell adhesion molecules (CAMs) | 2.3 | 3 | 1.80E-02 | 1.30E-01 |
Phagosome | 2.3 | 3 | 2.30E-02 | 1.50E-01 |
Enrichment scores as determined by Functional Annotation Clustering in DAVID v.6.8, which rank overall importance of the annotation term groups. AGA CON n = 6, AGA HF n = 6, SGA CON n = 6, SGA HF n = 6.
Main effect of diet (i.e., CON vs. HF); the Benjamini value corrects for multiple comparisons.
CON, control; HF, hydrolyzed fat.